Abstract:We tested the hypothesis that exogenous administration of the ET-1 precursor, bigET-1, would regulate adult rat ventricular myocyte (ARVM) contractility in a p38-mitogen activated protein kinase (p38-MAPK)-dependent mechanism during sepsis. Ventricular myocytes from adult rat hearts (both sham and septic) were stimulated to contract at 0.5 Hz and mechanical properties were evaluated using an IonOptix Myocam system. Immunoblot analysis was used to determine the phosphorylation of p38-MAPK and extracellular signal-regulated kinase 1/2 (ERK1/2). ARVMs were treated with vehicle, bigET-1 and inhibitors for 24 h and then subjected to functional and biochemical estimations. Septic ARVM displayed a distorted cell membrane and irregular network within the cells along with increased cell contractility as evidenced by elevated peak shortening (PS), maximal velocity of shortening (+dL/dt) and relengthening (−dL/dt) in comparison to sham ARVM. BigET-1 treatment caused ARVM enlargement in both sham and sepsis groups. BigET-1 (100 nM) produced an increase in ARVM contractility in sham group as compared to vehicle treatment. However, septic ARVM treated with bigET-1 exhibited unaltered ARVM contractility, and upregulated ETB receptors as compared to respective sham group. BigET-1 increased the concentration of ET-1 and upregulated phosphorylation of p38-MAPK but not of ERK1/2 in sham and septic ARVM. Furthermore, inhibition of p38-MAPK by SB203580 (10 μM) increased ARVM contractility in sham but not in sepsis group. BigET-1 reversed SB203580-induced increase in PS in sham group but accentuated it in sepsis group. BigET-1 also reversed SB203580-induced inhibition of p38-MAPK phosphorylation in sham but not in septic ARVM. SB203580 pretreatment followed by bigET-1 administration significantly decreased p38-MAPK phosphorylation and downregulated ETB receptor expression as compared to bigET-1 treatment per se in sepsis group but not in sham. We concluded that a bigET-1-induced non-responsive effect on septic ARVM contractile function could be due to upregulation of p38-MAPK phosphorylation and ETB receptor expression.

Intracellular Redistribution of Cardiac Endothelin-1 Receptor in Rat During Myocardial Hypertrophy.

Increased Myocardial Stiffness Activates Cardiac Microvascular Endothelial Cell Via VEGF Paracrine Signaling in Cardiac Hypertrophy

Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction.

ERK Expression and Activation in Myocardial Hypertrophy of Spontaneously Hypertensive Rats with Different Ages

Inhibition of Endothelin Converting Enzyme-1 Activity or Expression Ameliorates Angiotensin Ii-Induced Myocardial Hypertrophy in Cultured Cardiomyocytes

ALTERATION OF FUNCTIONAL RECEPTORS IN HEART FOR HUMAN UROTENSIN II IN PRESSURE-OVERLOADINDUCED CARDIAC HYPERTROPHY RATS

Subcellular remodeling and heart dysfunction in cardiac hypertrophy due to pressure overload

Alterations in ryanodine receptors in cardiac sarcoplasmi c reticulum and nuclear envelope isolated from cardiac hypertrophic rats

[Overexpression of Endothelin-1 Induces Hypertrophy of Rat Pulmonary Arterial Microvascular Smooth Muscle Cells Via Akt/mTOR Pathway].

Antiapoptotic effect of endothelin-1 in rat cardiomyocytes in vitro

Bigendothelin-1 via p38-MAPK-dependent mechanism regulates adult rat ventricular myocyte contractility in sepsis.

[Alteration of Cardiac Alpha 1-Adrenergic Receptor Subtypes in Cardiac Insufficient Rat].

Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy

Ca2+/calmodulin-dependent Kinase II and Calcineurin Play Critical Roles in Endothelin-1-induced Cardiomyocyte Hypertrophy.

Dopamine D2 Receptor Stimulation Inhibits Angiotensin II-induced Hypertrophy in Cultured Neonatal Rat Ventricular Myocytes.

Angiotensin II type 1 receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction

Rapid functional upregulation of vasocontractile endothelin ETB receptors in rat coronary arteries

A Novel Mechanism of Angiotensin II‐induced Cardiac Hypertrophy – the Role of Soluble Epoxide Hydrolase

Endothelin-converting Enzyme-1-mediated Signaling in Adult Rat Ventricular Myocyte Contractility and Apoptosis During Sepsis.

[Alteration of the Expression of Rat Cardiac Galphaq/11 and Gialpha2 Proteins During Endothelin-1 Pre-Treatment].

PERK-mediated Endoplasmic Reticulum Stress is Involved in Angiotensin II-induced Myocardial Hypertrophy